Testing effectiveness (Phase 2)Study completedNCT01378676
What this trial is testing
Evaluate the Effects of Multiple Doses of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Who this might be right for
Amyotrophic Lateral Sclerosis
Cytokinetics 49